## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 3.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($77.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Welch Group LLC Acquires 20,744 Shares of Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251223T140730 | Somewhat-Bullish | Relevance: 100%
- Welch Group LLC increased its stake in Colgate-Palmolive Company by 3.1% in the third quarter, purchasing 20,744 shares to bring its total holdings to 685,785 shares valued at approximately $54.82 million. This investment represents about 2.1% of Welch Group LLC's portfolio. Several other institutional investors also adjusted their positions in Colgate-Palmolive, reflecting varied sentiment towards the consumer products giant. Colgate-Palmolive recently reported strong quarterly earnings, beating EPS estimates, and declared a quarterly dividend of $0.52 per share.

**2. Who Owns Colgate-Palmolive? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251222T150839 | Neutral | Relevance: 100%
- This article details the top institutional shareholders of Colgate-Palmolive (NYSE: CL) and recent insider trading activity. It highlights that major institutional investors, particularly passive managers, dominate ownership, while active managers show mixed positions. Insider transactions lean towards minor selling, which doesn't indicate aggressive sentiment but rather a measured approach to current valuation.

**3. February 2026 Options Now Available For Colgate-Palmolive (CL)**
- Source: Nasdaq | 20251224T154044 | Somewhat-Bullish | Relevance: 100%
- New options for Colgate-Palmolive (CL) with a February 2026 expiration are now available. BNK Invest's YieldBoost formula identified a put contract at a $79.00 strike and a call contract at an $81.00 strike, offering specific strategies for investors. These options provide potential returns through premium collection based on the stock's current trading price of $80.07/share.

**4. Swedbank AB Acquires 376,541 Shares of Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251224T135503 | Somewhat-Bullish | Relevance: 100%
- Swedbank AB increased its stake in Colgate-Palmolive Company by 9.5% in the third quarter, acquiring 376,541 additional shares and bringing its total holdings to 4,328,511 shares valued at approximately $346.0 million. Despite recent price target adjustments by Wall Street analysts, Colgate-Palmolive maintains a "Moderate Buy" consensus rating with an average target price of $88.81. The company reported strong Q3 earnings, exceeding estimates, and declared a quarterly dividend of $0.52 per share with an ex-dividend date of January 21st.

**5. Legacy Wealth Asset Management LLC Has $1.89 Million Position in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251222T120803 | Somewhat-Bullish | Relevance: 100%
- Legacy Wealth Asset Management LLC significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) during Q3, now owning 23,612 shares valued at $1.89 million. Analysts maintain a "Moderate Buy" consensus for Colgate-Palmolive, with an average price target of $88.81. The company also declared a quarterly dividend of $0.52 per share, with an ex-dividend date of January 21st.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $88 | $87 | +1% |
| 2025-12-11 | Argus Research | $0 | $0 | 0% |
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-11 | Argus Research | down | Hold |
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 7 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Long-term trend broken: trading 6.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.00 signals overvaluation risk, limited margin of safety. Forward P/E 20.9x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $64.9B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.00 |
| Forward P/E | 20.9 |
| Current P/E | 22.0 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.6% to 0.9% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 57. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.92% (CS: 66) | Neutral |
| RSI_14 | 57.0 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 0.939x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $80.25
- **Stop Loss:** $77.55 (3.4% risk)
- **Target:** $82.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 222
- **Position Value:** $17,815.50
- **Portfolio %:** 17.82%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*